Optomed Q4 2025: €4.8M Revenue, €1.3M EBIT Loss, Cautious OutlookOptomed Oyj Q4 2025 results: €4.8 M revenue, €‑1.3 M EBIT due to one‑off cost, cautious outlook, shares down amid Helsinki market dip.Optomed Oyj Health Care Health Care Equipment & Services AI generated 11/02/2026, 10:21 2 minutes to read
